𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Applying Cytogenetic and Molecular Information in the Clinic: Implications for the Treatment of Chronic Myeloid Leukemia

✍ Scribed by Alfonso Quintás-Cardama; Hagop Kantarjian; Jorge E. Cortés

Book ID
119936291
Publisher
Elsevier
Year
2010
Tongue
English
Weight
124 KB
Volume
10
Category
Article
ISSN
2152-2650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute myeloid leukemia developing during
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities
✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been